OFS
BLUE

OneAscent Financial Services’s bluebird bio BLUE Stock Holding History

OneAscent Financial Services’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-161
Closed -$265K – 43
2019
Q2 		$265K Buy
+161
New +$279K 0.18% 134

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

OneAscent Financial Services's BLUE Position: Q3 2019 in Review

OneAscent Financial Services sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 161 shares — an estimated $265K sold.

OneAscent Financial Services first reported a position in BLUE in Q2 2019 and held it in 1 quarter. The position peaked at $265K in Q2 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • OneAscent Financial Services reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • OneAscent Financial Services sold 161 bluebird bio shares in Q3 2019, an estimated $265K.
  • OneAscent Financial Services first reported a position in bluebird bio in Q2 2019 and held it in 1 quarter.
  • OneAscent Financial Services's bluebird bio position peaked at $265K in Q2 2019.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on OneAscent Financial Services's 13F filing for Q3 2019, filed 15 Nov 2019.